Neurologists’ decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices

Thumbnail Image

Files

Neurologists' decision-making_2026 (866.91 KB)
Identifiers
URI: https://hdl.handle.net/11268/16860
DOI: 10.1177/22143602261420993

Publication date

2026

Authors

Gómez Ballesteros, Rocío
Ares, Adrián
Villaverde, Ramón
Reyes, Virginia

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

SDG

goal-3

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

The evolving landscape of generalised myasthenia gravis (gMG) treatment with new targeted immunotherapy options presents challenges for neurologists and potentially leads to therapeutic inertia (TI), the failure to initiate or intensify treatment when therapeutic goals are not met. This study aimed to assess neurologists’ therapeutic decision-making process in gMG and its influencing factors. A cross-sectional, web-based study was conducted, involving 149 neurologists.

Description

UNESCO Subjects

Neurología
Personal médico
Medicina preventiva

Keywords

Bibliographic reference

Gutiérrez-Gutiérrez, G., Gómez-Ballesteros, R., Ares, A., Villaverde, R., Reyes, V., Armangué, T., Díaz-Abós, P., Rebollo, P., Canal, N., Querol, L., Maurino, J., & Cortés-Vicente, E. (2026). Neurologists’ decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices. Journal of Neuromuscular Diseases, 22143602261420993. https://doi.org/10.1177/22143602261420993
Editor's version
https://doi.org/10.1177/22143602261420993

Type of document

journal article

Collections

Área de Ciencias de la Salud
Attribution-NonCommercial 4.0 International

La licencia de este ítem se describe como Attribution-NonCommercial 4.0 International